Skip to main content

Advertisement

SpringerLink
Log in

Fecal S100A12 in Takayasu arteritis predicts disease activity and intestinal involvement

  • Biomarkers
  • Published:
Rheumatology International Aims and scope Submit manuscript

Abstract

Gastrointestinal involvement in Takayasu Arteritis (TA) requires invasive or expensive diagnostic studies. Instead a fecal biomarker can be used as an initial screening test. In this context, S100A12 is promising as an established biomarker in intestinal inflammation and its role in TA pathogenesis. As such we aimed to test the feasibility of fecal S100A12 as a means of the fecal biomarker in gastrointestinal involvement in TA in this pilot study. Our study population consisted of 30 TA patients and 14 control patients with non-inflammatory arthralgia. Patients with inflammatory or infectious gastrointestinal tract diseases, or used oral antibiotics or NSAIDs for the 3 weeks were excluded. Vasculitis involvements were determined with cross-sectional radiologic studies. TA disease activity was evaluated per Indian Takayasu's Activity Score (2010) criteria and vascular involvements were classified according to Numano classification. ELISA test was used to determine fecal S100A12 levels. Fecal S100A12 levels were higher in TA patients when compared to the controls (37.9 ng/ml vs. 12.5 ng/ml p = 0.038). ESR and CRP levels were also higher in the TA group, however not correlated with fecal S100A12. Among TA patients, fecal S100A12 levels were higher inactive ones with ITAS2010 > 1 (72.9 ng/ml vs. 16.7 ng/ml p = 0.016) correlated with total ITAS2010 scores. (R = 0.52 p = 0.003). TA patients with abdominal symptoms had higher fecal S100A12 levels when compared to the remaining TA population (327.8 ng/ml vs. 28.0 ng/ml p = 0.003). However, fecal S100A12 levels in patients with or without mesenteric vessel involvement did not differ. Fecal S100A12 shows promise as a fecal biomarker to screen intestinal ischemia and inflammatory bowel disease in TA patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. Koster MJ, Warrington KJ, Matteson EL (2020) Morbidity and mortality of large-vessel vasculitides. Curr Rheumatol Rep 22(12):86

    Article  Google Scholar 

  2. Chung JW, Kim H-C, Choi YH, Kim SJ, Lee W, Park JH (2007) Patterns of aortic involvement in Takayasu arteritis and its clinical implications: evaluation with spiral computed tomography angiography. J Vasc Surg 45(5):906–914

    Article  Google Scholar 

  3. Mirouse A, Biard L, Comarmond C, Lambert M, Mekinian A, Ferfar Y et al (2019) Overall survival and mortality risk factors in Takayasu’s arteritis: a multicenter study of 318 patients. J Autoimmun 96:35–39

    Article  Google Scholar 

  4. Reny JL, Paul JF, Lefèbvre C, Champion K, Emmerich J, Blétry O et al (2003) Association of Takayasu’s arteritis and Crohn’s disease. Results of a study on 44 Takayasu patients and review of the literature. Ann Med Interne 154(2):85–90

    Google Scholar 

  5. Terao C, Matsumura T, Yoshifuji H, Kirino Y, Maejima Y, Nakaoka Y et al (2015) Takayasu arteritis and ulcerative colitis: high rate of co-occurrence and genetic overlap. Arthritis Rheumatol 67(8):2226–2232

    Article  Google Scholar 

  6. Esen SG, Armagan B, Atas N, Ucar M, Varan Ö, Erden A et al (2019) Increased incidence of spondyloarthropathies in patients with Takayasu arteritis: a systematic clinical survey. Joint Bone Spine 86(4):497–501

    Article  Google Scholar 

  7. Esatoglu SN, Ok AM, Ucar D, Celik AF, Ugurlu S, Hamuryudan V, et al (2020) Takayasu's arteritis: associated inflammatory diseases. Clin Exp Rheumatol 38(Suppl 124):61–68

  8. Schäfer VS, Jin L, Schmidt WA (2020) Imaging for diagnosis, monitoring, and outcome prediction of large vessel vasculitides. Curr Rheumatol Rep 22(11):76

    Article  Google Scholar 

  9. Watanabe R, Berry GJ, Liang DH, Goronzy JJ, Weyand CM (2020) Pathogenesis of Giant Cell Arteritis and Takayasu Arteritis-Similarities and Differences. Curr Rheumatol Rep 22(10):68

    Article  Google Scholar 

  10. Watanabe R, Berry GJ, Liang DH, Goronzy JJ, Weyand CM (2020) Cellular signaling pathways in medium and large vessel vasculitis. Front Immunol 11:587089

    Article  CAS  Google Scholar 

  11. Springer JM, Monach P, Cuthbertson D, Carette S, Khalidi NA, McAlear CA et al (2018) Serum S100 Proteins as a Marker of Disease Activity in Large Vessel Vasculitis. J Clin Rheumatol 24(7):393–395

    Article  Google Scholar 

  12. Mahajan N, Mahmood S, Jain S, Dhawan V (2013) Receptor for advanced glycation end products (RAGE), inflammatory ligand EN-RAGE and soluble RAGE (sRAGE) in subjects with Takayasu’s arteritis. Int J Cardiol 168(1):532–534

    Article  Google Scholar 

  13. Martins CD, Caon AER, Facanali CBG, Sobrado CW, Nahas SC, Pereira RMR, et al. Coexistence of Takayasu's Arteritis in Patients with Inflammatory Bowel Diseases. Gastroent Res Pract. 2021

  14. Carvalho A, Lu J, Francis JD, Moore RE, Haley KP, Doster RS et al (2020) S100A12 in digestive diseases and health: a scoping review. Gastroenterol Res Pract 2020:2868373

    Article  Google Scholar 

  15. Arend WP, Michel BA, Bloch DA, Hunder GG, Calabrese LH, Edworthy SM et al (1990) The American-College-of-Rheumatology 1990 Criteria for the Classification of Takayasu Arteritis. Arthritis Rheum 33(8):1129–1134

    Article  CAS  Google Scholar 

  16. Misra R, Danda D, Rajappa SM, Ghosh A, Gupta R, Mahendranath KM et al (2013) Development and initial validation of the Indian Takayasu Clinical Activity Score (ITAS2010). Rheumatology 52(10):1795–1801

    Article  Google Scholar 

  17. Hata A, Noda M, Moriwaki R, Numano F (1996) Angiographic findings of Takayasu arteritis: new classification. Int J Cardiol 54(Suppl):S155–S163

    Article  Google Scholar 

  18. Philpott HL, Nandurkar S, Lubel J, Gibson PR (2014) Drug-induced gastrointestinal disorders. Postgrad Med J 90(1065):411–419

    Article  CAS  Google Scholar 

  19. Kanitez NA, Toz B, Gulluoglu M, Erer B, Esen BA, Omma A et al (2016) Microscopic colitis in patients with Takayasu’s arteritis: a potential association between the two disease entities. Clin Rheumatol 35(10):2495–2499

    Article  Google Scholar 

  20. Sharma BK, Jain S, Sagar S (1996) Systemic manifestations of Takayasu arteritis: the expanding spectrum. Int J Cardiol 54:S121–S126

    Article  Google Scholar 

  21. Kabeerdoss J, Thomas M, Goel R, Mohan H, Danda S, L J, et al (2019) High expression of S100 calgranulin genes in peripheral blood mononuclear cells from patients with Takayasu arteritis. Cytokine 114:61–66

  22. Kabeerdoss J, Goel R, Mohan H, Danda D (2021) High expression of pro-inflammatory cytokine genes IL-1β and IL-1R2 upon TLR4 activation in Takayasu arteritis. Rheumatol Int. https://doi.org/10.1007/s00296-020-04785-0

    Article  PubMed  Google Scholar 

  23. Hayashida M, Miyoshi J, Mitsui T, Miura M, Saito D, Sakuraba A et al (2020) Elevated fecal calprotectin and lactoferrin associated with small intestinal lesions in patients with Behçet disease. J Gastroenterol Hepatol 35(8):1340–1346

    Article  CAS  Google Scholar 

  24. Goel R, Gribbons KB, Carette S, Cuthbertson D, Hoffman GS, Joseph G et al (2019) Derivation of an angiographically based classification system in Takayasu’s arteritis: an observational study from India and North America. Rheumatology 59(5):1118–1127

    Article  Google Scholar 

  25. Misra DP, Krishnan N, Gochhait D, Emmanuel D, Negi VS (2017) Takayasu arteritis (TA) first presenting with intestinal ischemia: a case report and review of gastrointestinal tract involvement (ischemic and non-ischemic) associated with TA. Rheumatol Int 37(1):169–175

    Article  Google Scholar 

  26. Simon S, Schittko G, Boesenberg H, Holl-Ulrich K, Schwarz-Eywill M (2006) Fulminant cours of a Takayasu’s arteritis and rare mesenteric arterial maninfestion. Z Rheumatol 65(6):520–526

    Article  CAS  Google Scholar 

  27. Däbritz J, Foell D, Wirth S, Jenke A (2013) Fecal S100A12: Identifying intestinal distress in very-low-birth-weight infants. J Pediatr Gastroenterol Nutr 57(2)

  28. Olano C, Cohen H (2018) Video capsule endoscopy diagnosis of Takayasu’s arteritis. Endoscopy 50(3):E52–E53

    Article  Google Scholar 

  29. Akiyama S, Fujii T, Matsuoka K, Yusuke E, Negi M, Takenaka K et al (2017) Endoscopic features and genetic background of inflammatory bowel disease complicated with Takayasu arteritis. J Gastroenterol Hepatol 32(5):1011–1017

    Article  CAS  Google Scholar 

  30. Kilic L, Kalyoncu U, Karadag O, Akdogan A, Dogan I, Bilgen SA et al (2016) Inflammatory bowel diseases and Takayasu’s arteritis: coincidence or association? Int J Rheum Dis 19(8):814–818

    Article  CAS  Google Scholar 

  31. Bekele DI, Warrington KJ, Koster MJ (2021) Giant cell arteritis associated with inflammatory bowel disease: a case-series and review of the literature. Rheumatol Int 41(2):487–492

    Article  Google Scholar 

  32. Azak A, Huddam B, Kocak G, Kilic F, Kocak E, Duranay M (2012) Takayasu Arteritis and Ulcerative Colitis; Coexistence or Misdiagnosis? Sarcoidosis Vasculitis Diffuse Lung Dis 29(1):53–54

    CAS  Google Scholar 

  33. Yilmaz N, Can M, Alibaz-Oner F, Direskeneli H (2013) Clinically silent Crohn’s disease in a patient with Takayasu’s arteritis unresponsive to conventional therapies. Rheumatol Int 33(12):3091–3093

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Gastroenterology, Hacettepe University Faculty of Medicine, 06100, Sihhiye, Turkey

    Simsek Cem

  2. Division of Rheumatology, Hacettepe University Faculty of Medicine, Sihhiye, Turkey

    Armagan Berkan, Sari Alper, Emet Abdulsamer, Kilic Levent & Akdogan Ali

Authors
  1. Simsek Cem
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Armagan Berkan
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Sari Alper
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Emet Abdulsamer
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Kilic Levent
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Akdogan Ali
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

Conception and design of the study: CS, BA, AA, AS acquisition of data: CS, BA, AS, AA analysis and/or interpretation of data: CS, BA, AA. Drafting the manuscript: CS, BA; revising the manuscript critically for important intellectual content: BA, AA, AS. Approval of the version of the manuscript to be published: CS, BA, AA, AS, LK, AE.

Corresponding author

Correspondence to Simsek Cem.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Cem, S., Berkan, A., Alper, S. et al. Fecal S100A12 in Takayasu arteritis predicts disease activity and intestinal involvement. Rheumatol Int 42, 737–742 (2022). https://doi.org/10.1007/s00296-021-04981-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00296-021-04981-6

Keywords

Search

Navigation